Skip to main content

Table 1 Patient Demographic characteristics at baseline

From: Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial

Characteristics   A (n = 82) B (n = 70) C (n = 70) p-value
Sex (Female), n   41 42 42 0.35
Age, y 35.16 ± 8.21 37.11 ± 6.56 34.41 ± 6.19 0.27
BMI (Kg/m2) 24.78 ± 8.34 24.76 ± 8.54 24.42 ± 7.70 0.17
Migraine type, n Without Aura 51 39 44 0.62
With Aura 31 31 26
Headache history, y 5.23 ± 2.49 5.73 ± 2.14 4.89 ± 3.14 0.25
Family history of migraine, n Yes 55 43 47 0.71
No 27 27 23